Lexicon Pharmaceuticals, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 45.06M | $70.29M | 0.00% | Added+19.1% | 2026-03-31 |
| Citadel | multi-strat | 7.81M | $12.19M | 0.02% | Added+2651.4% | 2026-03-31 |
| RenTech | quant | 1.60M | $2.50M | 0.00% | Added+508.0% | 2026-03-31 |
| TwoSigma | quant | 1.20M | $1.87M | 0.00% | Added+88.2% | 2026-03-31 |
| StateStreet | passive | 964.0K | $1.50M | 0.00% | Added+9.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | -0.05 | — | — |
| 2026-05-07 | -0.04 | — | +100.00% |
| 2026-03-05 | -0.07 | -0.04 | +43.65% |
| 2025-11-06 | -0.07 | -0.04 | +39.44% |
| 2025-08-06 | -0.08 | 0.01 | +112.90% |
| 2025-05-13 | -0.10 | -0.07 | +32.26% |
| 2025-03-06 | -0.12 | -0.09 | +27.86% |
| 2024-11-12 | -0.17 | -0.18 | -7.52% |
| 2024-08-01 | -0.19 | -0.17 | +8.79% |
| 2024-05-02 | -0.20 | -0.20 | — |
| 2024-03-11 | -0.23 | -0.20 | +11.59% |
| 2023-11-08 | -0.22 | -0.21 | +4.55% |
| 2023-08-03 | -0.16 | -0.22 | -33.33% |
| 2023-05-02 | -0.16 | -0.17 | -6.25% |
| 2023-03-02 | -0.13 | -0.16 | -19.53% |
| 2022-11-09 | -0.14 | -0.13 | +7.20% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| LXRX | +33.74% | +35.40% | +89.57% | +246.03% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +30.77% | +40.04% | +93.01% | +233.34% |